Messenger RNA-based vaccines (Q35842616)

10 August 2017

1 reference

title

Messenger RNA-based vaccines (English)

1 reference

10 August 2017

1 reference

Steve Pascolo

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

Expert Opinion on Biological Therapy

10 August 2017

published in

1 reference

10 August 2017

1 reference

10 August 2017

1 reference

10 August 2017

page(s)

1285-1294

1 reference

The antiquity of RNA-based evolution

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

Functional Evidence for an RNA Template in Telomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

RNA interference is mediated by 21- and 22-nucleotide RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

T cell memory, anergy and immunotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

Emerging clinical applications of RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

Genetic immunization is a simple method for eliciting an immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

Quantitating protein synthesis, degradation, and endogenous antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

Protein degradation and the generation of MHC class I-presented peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

DNA vaccines: safety and efficacy issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

Direct gene transfer into mouse muscle in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

Self-replicating Semliki Forest virus RNA as recombinant vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

Cancer therapy using a self-replicating RNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

Intra-pinna anti-tumor vaccination with self-replicating infectious RNA or with DNA encoding a model tumor antigen and a cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

Dendritic cells transfected with cytopathic self-replicating RNA induce crosspriming of CD8+ T cells and antiviral immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

Microparticle-mediated RNA immunization against bovine viral diarrhea virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

Dendritic cells reconstituted with human telomerase gene induce potent cytotoxic T-cell response against different types of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

Transfection of dendritic cells with RNA induces CD4- and CD8-mediated T cell immunity against breast carcinomas and reveals the immunodominance of presented T cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

Generation of cytotoxic responses in mice and human individuals against hematological malignancies using survivin-RNA-transfected dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

Generation of Ag-specific cytotoxic T lymphocytes by DC transfected with in vitro transcribed influenza virus matrix protein (M1) mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

The generation of LMP2a-specific cytotoxic T lymphocytes for the treatment of patients with Epstein-Barr virus-positive Hodgkin disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

HIV gag mRNA transfection of dendritic cells (DC) delivers encoded antigen to MHC class I and II molecules, causes DC maturation, and induces a potent human in vitro primary immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

RNA-transfected CD40-activated B cells induce functional T-cell responses against viral and tumor antigen targets: implications for pediatric immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

Endogenous neosynthesis vs. cross-presentation of viral antigens for cytotoxic T cell priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

Immunotherapy with Autologous, Human Dendritic Cells Transfected with Carcinoembryonic Antigen mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

Induction of Cytotoxic T Lymphocytes With Dendritic Cells Transfected With Human Papillomavirus E6 and E7 RNA: Implications for Cervical Cancer Immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

Synergy between tumor immunotherapy and antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1285

10.1517/14712598.4.8.1285

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference